- All address
- BFA,Main Hall,Level 2
- BFA,Main Hall1/2-A,Level 2
- BFA,Main Hall1/2-B,Level 2
- BFA,Dong Yu Grand Ballroom A
- BFA,Dong Yu Grand Ballroom B
- BFA,Dong Yu Grand Ballroom C
- BFA,Dong Yu Grand Ballroom D
- BFA,Peacock Room 1
- Dongyu,Changyan room(Wanquan Ballroom 1/3)
- Dongyu,Yiyong room(Wanquan Ballroom 1/3)
- Dongyu,Hesheng room(Wanquan Ballroom 1/3)
- BFA,The Pavilion
- BFA,Oriental Theatre
- ALL
- Food Regulations and Standards——Latest Progress in Regulations and Standards
- Food Regulations and Standards——Current Status and Challenges of Food Claims
- Food Regulations and Standards——Nutrition Policy
- New Technologies and New Products——Foods from Synthetic Biology
- New Technologies and New Products——Efficacy and Evidence-Based Applications of Ergothioneine
- New Technologies and New Products——New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications
- New Technologies and New Products——Functional Lipids and Nutritional Health Research
- New Technologies and New Products——Innovation of Algal Oil Omega-3 (EPA+DHA) and Evidence-Based Verification of Its Human Health Functions
- Medicine and Food Homology (MFH)——Comprehensive Topics
- Medicine and Food Homology (MFH) ——Goji Berry
- Sports Foods——Comprehensive Theme
- Sports Foods——Sports Drink
- Sports Foods——Sports Nutritional Food
- Sports Foods——Roundtable Meeting
- Foods for Special Medical Purposes (FSMPs)——Accelerating Market Access to Improve the Availability of Special Medical Foods
- Foods for Special Medical Purposes (FSMPs)——Industry Empowerment:New Perspectives on Medical Food
- Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting
- Probiotics Session 1——Precision Nutrition and Personalized Probiotic Solutions
- Probiotics Session 2——Probiotics and Prebiotics:Supporting whole life-cycle health 2.0
- Probiotics Session 3——Synthetic Biology and Next-Generation Probiotic Development
- Probiotics Session 4——From Gut to Brain,Skin,and Metabolism
- Postbiotics Session
- Prebiotics Session——A Fresh Perspective on Gut Health – From Discomfort to Holistic Wellness
- Healthy Grains——Whole Grain Foods and Health
- Section VII:Healthy Grains——Section2:Low-GI Staple Foods and Health
- Infant and Toddler Formula Milk Powder and Complementary Food——Tracking Scientific Research Achievements and Ingredient Innovation
- Infant and Toddler Formula Milk Powder and Complementary Food——Precise Formulation and Clinical Evidence
- Infant and Toddler Formula Milk Powder and Complementary Food——Infant Complementary Food
Sessions
Section I:Food Regulations and Standards——Session 1:Latest Progress in Regulations and Standards |
2026-03-12 14:00-16:50 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator:Huo Junsheng,Research Fellow,National Institute for Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-12 14:00-14:20 Challenges and Reflections on the Administration of Infant Formula and Medical FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:20-14:40 New Progress in the Administration of Health FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:40-15:00 Practice in the Evaluation of New Functions of Health FoodsLiu Hongyu,Division Director,Food Evaluation Center of the State Administration for Market Regulation |
| 2026-03-12 15:00-15:20 Development of the List of Health Food Raw MaterialsSayi,Director of the Health Food Safety Evaluation Department,Food Evaluation Center,National Market |
| 2026-03-12 15:20-15:35 Reflections on the R&D of Milk Components and the Formulation of Their StandardsWang Jun Research Fellow,China National Center for Food Safety Risk Assessment |
| 2026-03-12 15:35-15:50 Latest Updates on Food Standards for Special Medical Purposes (FSMP)Fang Haiqin Researcher,Nutrition Room 1，China National Center for Food safety Risk AssessmentDirector |
| 2026-03-12 15:50-16:05 Policy Practice of Temporary Import of Food for Special Medical Purposes (FSMP) and Health Food in Hainan Boao Lecheng Pilot ZoneWanshuang,Director of Pharmaceutical and Medical Device Department,Boao Lecheng International Medical Tourism Pilot Zone Administration,Hainan |
| 2026-03-12 16:05-16:40 Q&AModerator: |
Section I:Food Regulations and Standards——Session 3:Nutrition Policy |
2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom A |
| |
| 2026-03-14 09:00-09:30 National Nutrition Policies |
| 2026-03-14 09:30-10:00 Dietary Guidelines for Chronic Diseases Series |
| 2026-03-14 10:00-10:30 Key Tasks and Future Plans of the National Nutrition Plan for 2026Zhihong Wang Research Fellow,Deputy Director of，Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 10:30-11:00 Nutrition and Health Standards and Their Formulation DirectionZhang Bing Researcher,Deputy Director of the Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 11:00-11:30 Agricultural and Food Nutrition Policies and Standards |
| 2026-03-14 11:30-12:00 Roundtable Meeting:Healthy Food High-Quality Development Led by Nutrition Policies and StandardsModerator: |
Section II:New Technologies and New Products——Session 1:Foods from Synthetic Biology |
2026-03-12 13:30-17:30 BFA,Oriental Theatre |
Moderators： |
| 2026-03-12 13:30-13:50 Management Status,Future Prospects and Key Challenges of Synthetic Biology-Derived Novel Food Ingredients |
| 2026-03-12 13:50-14:10 Developing cell factories for edible mycoprotein biomanufacturing |
| 2026-03-12 14:10-14:30 |
| 2026-03-12 14:30-14:50 Pilot Production and Comprehensive Safety Assessment of In Vitro Cultured Porcine Meat |
| 2026-03-12 14:50-15:10 Precision-Fermented Lactoferrin:Functional Validation,Commercialisation and Advances Towards Human-Identical Lactoferrin |
| 2026-03-12 15:10-15:30 The Era of Functional Dairy Ingredient Biosynthesis:Technological Breakthroughs and Industrialization Pathways,Using HMO,OPN as Examples |
| 2026-03-12 15:30-15:50 Biomanufacturing of Functional Food Components Driven by Artificial Intelligence |
| 2026-03-12 15:50-17:00 Roundtable Meeting：Development and Challenges of Synbio FoodsModerators: |
| 2026-03-12 17:00-17:10 |
Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine |
2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderator：He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation |
| 2026-03-14 09:00-09:20 Synthetic biology of ergothioneine in edible mushrooms and its anti-aging effects |
| 2026-03-14 09:20-09:40 Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence |
| 2026-03-14 09:40-10:00 Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies |
| 2026-03-14 10:00-10:20 Redefining Dietary Supplements with Evidence-Based Science and Human Clinical Evidence |
| 2026-03-14 10:20-10:40 The protective effect of ergothioneine on oxidative damage of nerve cells |
| 2026-03-14 10:40-11:00 Ergothioneine:Efficacy Research and Regulatory Status |
| 2026-03-14 11:00-11:55 Roundtable Meeting：The Development Path of Ergothioneine in ChinaModerator: |
| 2026-03-14 11:55-12:00 |
Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications |
2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderators: |
| 2026-03-14 08:30-08:50 Chinese HMOs Profile:Research and Application |
| 2026-03-14 08:50-09:10 Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults |
| 2026-03-14 09:10-09:30 The trends of regulatory management of HMOs |
| 2026-03-14 09:30-09:50 The Potential Application Value of HMOs in the Field of Healthy Aging |
| 2026-03-14 09:50-10:10 Research on the Effect of Human Milk Oligosaccharides on Brain Development |
| 2026-03-14 10:10-10:30 From the Wisdom of Breast Milk to Clinical Promise:HMOs and Probiotics in Synergy to Protect Preterm Infant Gut Health |
| 2026-03-14 10:30-10:50 The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways |
| 2026-03-14 10:50-11:10 Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio |
| 2026-03-14 11:10-11:30 Global Trends in HMO Research and Applications |
| 2026-03-14 11:30-12:00 Roundtable Meeting：Risks of Biosynthetic Human Milk Oligosaccharides (HMOs) Applied in the Production of Infant and Toddler Formula Milk PowderModerator: |
Section II:New Technologies and New Products——Session 4:Functional Lipids and Nutritional Health Research |
2026-03-13 08:30-18:00 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderator:Wang Xingguo,Professor,Jiangnan University |
| 2026-03-13 08:30-08:50 Guiding report:Health prospects for functional oils |
| 2026-03-13 08:50-09:20 Ocean-derived Omega-3 fatty acids and health:From molecular mechanisms to new nutrition strategies throughout the life cycle |
| 2026-03-13 09:20-09:50 Prospective dietary fat assessment using human metabolic chambers,nutritional challenges,and interventions |
| 2026-03-13 09:50-10:15 The requirements for fat and fatty acids in special dietary foods |
Recess |
| 2026-03-13 10:30-10:55 Nutritional mechanisms and strategies of food lipids regulating brain health |
| 2026-03-13 10:55-11:20 Fat-gut microbiome interaction and metabolic health |
| 2026-03-13 11:20-11:45 Fat nutrition and metabolism in maternal and child health--Molecular epidemiological study |
| 2026-03-13 11:45-12:10 Effects of different ratios of n6/n3 oils on health |
Noon break |
| 2026-03-13 13:25-13:55 n-3 fatty acids improve cognitive function by regulating epigenetic genes |
| 2026-03-13 13:55-14:20 Nutritional Functions and Applications of high sn-2 DHA Functional Lipids |
| 2026-03-13 14:20-14:45 ASSESSMENT OF DIETARY TOTAL FAT,SATURATED FATTY ACID AND UNSATURATED FATTY ACID INTAKE IN CHINESE RESIDENTS |
| 2026-03-13 14:45-15:10 AI+ intelligent manufacturing empowers the development of functional oils |
| 2026-03-13 15:10-15:35 Eat more healthy:Yihai-Kerry's research development in functional oils |
| 2026-03-13 15:35-16:00 Structured Lipids for Improving Malnutrition in Patients with Chronic Obstructive Pulmonary Disease:A Randomized Clinical Study |
| 2026-03-13 16:00-16:25 Functional fats for life cycle nutrition |
| 2026-03-13 16:25-16:50 The Difference of One Ester Bond:A Breakthrough Approach for the Health Upgrade of China's Oils and Fats Industry |
Recess |
| 2026-03-13 17:00-18:00 Roundtable MeetingModerator: |
Section II:New Technologies and New Products——Session 5:Innovation of Algal Oil Omega-3 (EPA+DHA) and Evidence-Based Verification of Its Human Health Functions |
2026-03-12 13:00-16:00 BFA,The Pavilion |
Moderators:Prof. Shan Zhilei,School of Public Health,Tongji Medical College,Huazhong University of Science and Technology;Pan Yu,Director of Scientific Affairs,DSM-Firmenich Greater China |
| 2026-03-12 13:00-13:25 Leading the global innovation and new breakthroughs in clinical evidence of algal Omega-3 |
| 2026-03-12 13:25-13:55 In-depth interpretation of DO Health,the world's largest anti-aging clinical research |
| 2026-03-12 13:55-14:20 The crucial role of Omega-3 in metabolic health |
| 2026-03-12 14:20-14:45 The scientific potential of the anti-inflammatory mechanism of Omega-3 in health management |
| 2026-03-12 14:45-15:05 The latest clinical research on the reduction of preterm birth by Omega-3 for guiding pregnant nutrition |
| 2026-03-12 15:05-15:30 Health Benefits of Life's Nutritional Lipids for Children and Teenagers |
| 2026-03-12 15:30-16:00 Roundtable MeetingModerator: |
Section III:Medicine and Food Homology (MFH)——Session 1:Comprehensive Topics |
2026-03-12 13:00-17:10 BFA,Dong Yu Grand Ballroom A |
Moderator:Chen Min,Research Fellow,Chairman of the Professional Committee for Evaluation and Utilization of Medicine and Food Homology Substances,China Association of Chinese Materia Medica;LI Hongmei Researcher,Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences，Director of the Center for Toxicological Research on Traditional Chinese Medicine |
| 2026-03-12 13:00-13:10 |
| 2026-03-12 13:10-13:40 Current Development Status and Future Trends of the Global Functional Food Industry |
| 2026-03-12 13:40-14:00 National Priority Work on Food and Medicinal Materials |
| 2026-03-12 14:00-14:20 Health Preservation Philosophy Based on the Spleen-Stomach Theory and Its Contemporary Practice |
| 2026-03-12 14:20-14:40 Interpretation of the Evaluation System and Standards for Nutraceutical Medicinal Diets |
| 2026-03-12 14:40-15:00 From Traditional Insights to Modern Clinical Medicine:The Application of Homology of Medicine and Food in Preventive Healthcare |
| 2026-03-12 15:00-15:20 Application of the Medicine-Food Homology Concept in Nestlé's R&D and Innovation |
| 2026-03-12 15:20-15:40 Innovation and Practice in Immune Efficacy Evaluation of Compound Polysaccharides Derived from Medicinal and Edible Substances |
| 2026-03-12 15:40-16:00 From Cellular Level to Organ Level:Plant-Derived Scientific Anti-Aging Solutions |
| 2026-03-12 16:00-16:20 Admission Standards for Medicinal and Edible Homologous Products in the "Medicine-Food Homology Database"YANG GUANG Associate Researcher,National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences，Director of the Department |
| 2026-03-12 16:20-16:35 Launch Ceremony of China’s Medicinal &Edible Homology Industry Development Report 2025 |
| 2026-03-12 16:35-17:30 Roundtable Meeting：Standards for Food and Medicine Homology Substances and ProductsModerator: |
Section III:Medicine and Food Homology (MFH) ——Session 2:Goji Berry |
2026-03-12 16:10-18:40 BFA,The Pavilion |
Moderator:Zhexiong Yu Intermediate Engineer,NINGXIA TIANREN GOJI BIOTECHNOLOGYExecutive Director |
Keep Pace with Global Health Food Tech,Fuel Industrial Innovation:Wolfberry’s High-Value Development Model |
| 2026-03-12 16:10-16:15 |
| 2026-03-12 16:20-16:25 Speech by LeaderTBC |
| 2026-03-12 16:25-16:40 Guiding Report:Goji Berry and Human Health |
| 2026-03-12 16:40-17:00 Research on the Material Basis of Medicine-Food Homology Contributes to Developing Potential New Drugs for Parkinson's Disease |
| 2026-03-12 17:00-17:20 Exploration and Development of "Medicine-Food Homology"in the Eye Health Market — A Case Study of Wolfberry |
| 2026-03-12 17:20-17:35 Research Progress on the Main Active Components of Lycium barbarum |
| 2026-03-12 17:35-17:50 From Traditional Herb to Functional Food:The Evolution and Brand Story of Black Wolfberry |
| 2026-03-12 17:50-18:05 Efficient Exploration and Commercial Application of High-Value Added Active Compounds from Goji Berry |
| 2026-03-12 18:05-18:35 Roundtable Meeting：Market Changes and New Transformation Paths of Wolfberry ProductsModerator: |
| 2026-03-12 18:35-18:40 Conference Summary and Closing |
Section IV:Sports Foods——Session 1:Comprehensive Theme |
2026-03-13 09:00-10:20 BFA,Dong Yu Grand Ballroom C |
Moderator:Professor Qiu Junqiang,Head of the Exercise Biochemistry Division,School of Human Movement Sciences,Beijing Sport University |
The Scientific Rationale Underpinning Sports Nutrition Products |
| 2026-03-13 09:00-09:20 Guiding Report:Sports Nutrition in the Context of Healthy China |
| 2026-03-13 09:20-09:40 A Senolytic Sports Supplement for Muscle Renewal：Senactiv® |
| 2026-03-13 09:40-10:00 The Science of Sports Nutrition:From Protein Principles to Practice |
| 2026-03-13 10:00-10:20 Procedures and Methods for Evaluating the Efficacy of Sports Nutraceuticals |
Section IV:Sports Foods——Session 2：Sports Drink |
2026-03-13 10:40-12:00 BFA,Dong Yu Grand Ballroom C |
Moderator:LIU Feng,Life Science - Senior Director，PepsiCo R&D |
| 2026-03-13 10:40-11:00 Hydration strategy from intensive sports to daily exercise |
| 2026-03-13 11:00-11:20 Exercise-Related Dehydration in Women:Key Characteristics and Practical Prevention Strategies |
| 2026-03-13 11:20-11:40 Sweat Physiological Characteristics in the Chinese Population |
| 2026-03-13 11:40-12:00 Differentiation in Sports Drink Selection:Evidence and Recommendations |
Section IV:Sports Foods——Session 3：Sports Nutritional Food |
2026-03-13 14:00-15:20 BFA,Dong Yu Grand Ballroom C |
Moderator:Professor Qiu Junqiang,Head of the Exercise Biochemistry Division,School of Human Movement Sciences,Beijing Sport University |
| 2026-03-13 14:00-14:20 MFGM for Supporting Immune Health in Sports and Active Lifestyles |
| 2026-03-13 14:20-14:40 From Evidence to the Future:A Full-Chain Exploration of How Sports Nutrition Empowers Efficient Muscle Gain |
| 2026-03-13 14:40-15:00 Nutritional Support for Long-Distance Endurance Sports:Personalized Design and Systematic Implementation |
| 2026-03-13 15:00-15:20 Casein:Designed by Nature Timed Release Protein System for Athletes |
Section IV:Sports Foods——Roundtable Meeting |
2026-03-13 15:30-16:30 BFA,Dong Yu Grand Ballroom C |
| 2026-03-13 15:30-16:30 Roundtable Meeting:Technological Innovation and Challenges of Sports Nutrition FoodsModerators: |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 1:Accelerating Market Access to Improve the Availability of Special Medical Foods |
2026-03-13 13:00-14:30 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 13:00-13:15 Guiding Report:A Decade of Development Review and Future Outlook for Food for Special Medical Purposes (FSMP) |
| 2026-03-13 13:15-13:30 Development Trends and Challenges in the Application Policies for Foods for Special Medical Purposes (FSMP) |
| 2026-03-13 13:30-13:45 Market Access Status and Channels of Medical Food Products in Europe |
| 2026-03-13 13:45-14:00 Learning from Other Asia Pacific Countries:Application of FSMP in Singapore and Australia |
| 2026-03-13 14:00-14:15 Metabolic Modulation:The Path of Nutritional Intervention in Disease Prevention and Treatment |
| 2026-03-13 14:15-14:30 Medical Food in Taiwan:Marketing Strategies Under Stringent Regulatory Framework |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 2:Industry Empowerment:New Perspectives on Medical Food |
2026-03-13 14:40-16:25 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 14:40-14:55 Food for Special Medical Purpose 2.0:The Era of Real Food |
| 2026-03-13 14:55-15:10 Clinical Practice and Existing Challenges of Partially Hydrolyzed Protein-Based Formulas |
| 2026-03-13 15:10-15:25 Specific nutrition formulation (Fortasyn Connect) with proven clinical benefits in preventing memory decline in aMCI / early AD) |
| 2026-03-13 15:25-15:40 Design Strategies for Special Nutritional Products Targeting Blood Glucose Management in Patients with Renal Dialysis Requirements |
| 2026-03-13 15:40-15:55 The Role of Custom-Tailored and Optimized Whey Protein Formulas in Nutritional Management of Chronic Kidney Disease (CKD) |
| 2026-03-13 15:55-16:10 Caseinates in medical nutrition:indispensable and versatile |
| 2026-03-13 16:10-16:25 Latest Evidence for Oral Nutrition Solutions (ONS) for Oncology:Benefits of high protein and omega-3 enriched ONS on outcomes in cancer patients undergoing treatment. |
Section V:Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting |
2026-03-13 16:30-17:00 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
| 2026-03-13 16:30-17:00 Roundtable Meeting:Discussing the Future of Specialty Medicine:How do you envision the future of specialty medicine in China,and what are some of the pressing issues that need to be addressed?Moderator: |
Section VI:Probiotics,Prebiotics and Postbiotics——Probiotics Session 1:Precision Nutrition and Personalized Probiotic Solutions |
2026-03-12 13:30-16:05 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-12 13:30-13:35 Opening Speech |
| 2026-03-12 13:35-13:55 Global Development Landscape of Probiotics,Prebiotics,and Postbiotics |
| 2026-03-12 13:55-14:15 State-of-the-Art Progress in Gut Microbiota and Precision Nutrition:From Research to Translation |
| 2026-03-12 14:15-14:35 Differential Energy Metabolism to Dietary Challenge Predict Weight Loss for Precision Nutrition |
| 2026-03-12 14:35-14:55 Gut Microecology from the Perspective of Precision Nutrition:Probiotics Supporting Metabolic Balance. |
| 2026-03-12 14:55-15:15 Innovation &Branding Integration:Hi188,the Growth-Promoting Probiotic |
| 2026-03-12 15:15-15:35 Formulation Innovations in Individualized Probiotic Products |
| 2026-03-12 15:35-16:05 Roundtable Meeting:Precision Nutrition and Personalized Probiotic Solutions:From Scientific Evidence to CommercializationModerator： |
Section VI:Probiotics,Prebiotics and Postbiotics——Probiotics Session 3:Synthetic Biology and Next-Generation Probiotic Development |
2026-03-13 09:00-12:00 BFA,Main Hall1/2-A,Level 2 |
| |
| 2026-03-13 09:00-09:05 |
| 2026-03-13 09:05-09:25 Clinical Evidence:New Strategies to Drive Probiotic Viability and Efficacy Research |
| 2026-03-13 09:25-09:45 Construction of an Ultrahigh-Throughput Microbial Screening Platform Based on Automation and Multidimensional Phenotyping:Industrial Application |
| 2026-03-13 09:45-10:00 The patented strain CCFM8631 empowers body management,from metabolic regulation mechanisms to clinical evidence |
| 2026-03-13 10:00-10:15 From Concept to Gold Standard:Clinical Validation Reshaping the Core Competitiveness of Probiotic Products |
| 2026-03-13 10:15-10:35 From Mechanistic Exploration to Population Validation:Evidence-Based Medical Research on Seven-Strain Compound Probiotics and Their Functional Yogurt |
| 2026-03-13 10:35-10:55 Health Benefits of Probiotic Supplementation in Early Life:A Population-Based Real-World Study of 10,000 Subjects |
| 2026-03-13 10:55-11:10 From Research to Commerce:Health Solutions Targeting Gut Microbiota |
| 2026-03-13 11:10-11:30 Clinical Evidence-Based Research Progress of Highly Active Spore Probiotic BC99 |
| 2026-03-13 11:30-11:55 Launch of Highly Active Spore Probiotic BC99 |
| 2026-03-13 11:55-12:00 Application Launch of Highly Active Probiotic Products |
Section VI:Probiotics,Prebiotics and Postbiotics——Probiotics Session 4:From Gut to Brain,Skin,and Metabolism |
2026-03-12 16:15-18:05 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-12 16:15-16:35 Scientific Breakthroughs Driving Innovation in Probiotic Products |
| 2026-03-12 16:35-16:55 Gut-Brain-Metabolic Axis:Unlocking Probiotic Potential for Holistic Health |
| 2026-03-12 16:55-17:15 Gut-Brain Axis and HRB Bifidobacterium for Healthy Aging |
| 2026-03-12 17:15-17:35 Gut Microbiota:Diverse Strategies and Synergistic Mechanisms for Gut-Brain Axis Intervention in Parkinson's Disease |
| 2026-03-12 17:35-18:05 Roundtable MeetingModerator: |
Section VI:Probiotics,Prebiotics and Postbiotics——Postbiotics Session |
2026-03-14 09:00-11:00 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-14 09:00-09:20 A Novel Fermented Oat with Postbiotic Effect:Design Strategies and Scientific Basis |
| 2026-03-14 09:20-09:40 Post LB Postbiotics and the Intestinal Barrier:Current Scientific Evidence and Novel Insights |
| 2026-03-14 09:40-10:00 Postbiotics Along the Gut–Brain Axis:LAC‑Living+ as a Clinically Evidenced Driver of New Growth in Emotional Well‑Being |
| 2026-03-14 10:00-10:20 New Randomized Controlled Trial Findings of Gastric-Derived Lactobacillus johnsonii LJ88 for Gastric Health |
| 2026-03-14 10:20-11:00 |
Section VI:Probiotics,Prebiotics and Postbiotics——Prebiotics Session:A Fresh Perspective on Gut Health – From Discomfort to Holistic Wellness |
2026-03-13 09:10-10:40 BFA,Peacock Room 1 |
Prebiotics Symposium:A Fresh Perspective on Gut Health – From Discomfort to Holistic Wellness |
| 2026-03-13 09:10-09:40 Dietary Interventions Improve Gastrointestinal Discomfort. |
| 2026-03-13 09:40-10:10 Innovating for digestive comfort:MRI assessment of low-lactose,high-GOS milk digestion in healthy Chinese adults |
| 2026-03-13 10:10-10:40 AI driven precision prebiotic innovation - reshaping the future of gut microbiota |
Section VII:Healthy Grains——Section2:Low-GI Staple Foods and Health |
2026-03-13 14:00-16:20 BFA,Dong Yu Grand Ballroom D |
| |
| 2026-03-13 14:00-14:20 |
| 2026-03-13 14:20-14:35 Clinical Study on Low GI Rice in Reducing Postprandial Blood Glucose Fluctuations |
| 2026-03-13 14:35-14:50 The Scientific Truth About the GI Values of Cereal Foods:Whole Grains ≠ Low GI |
| 2026-03-13 14:50-15:05 Group Standard for Naturally Low Glycemic Index Rice:Scientific Basis and Industrial Implementation |
| 2026-03-13 15:05-15:20 Research on the Efficacy Mechanism and Innovation of the Whole Industry Chain Model of Low-Glycemic-Index (GI) Sweet Corn |
| 2026-03-13 15:20-15:35 The Scientific Revolution of Low-GI Rice:A Comprehensive Scientific Evaluation System for the Entire Supply Chain,From a Single Seed to the Table of the Common People. |
| 2026-03-13 15:35-16:10 Roundtable MeetingModerator:Liu Yanfang |
| 2026-03-13 16:10-16:20 Launching Ceremony of the Cooperation on Family Healthy Kitchen between Ping An Health Insurance and Academician Chen Junshi's Workstation |
| 2026-03-13 16:20-16:30 |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 1:Tracking Scientific Research Achievements and Ingredient Innovation |
2026-03-13 13:30-15:50 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderators:Lai Jianqiang Research Fellow,Chinese Center for Disease Control and Prevention Chronic Disease and Aging Health Administration;Liu Biao Senior Engineer,Inner Mongolia Yili Industrial Group Co.,Ltd，R&D Director |
| 2026-03-13 13:30-13:35 |
| 2026-03-13 13:35-13:50 Guiding Report： Precision Formulation Design and Biofabrication of Next-Generation Infant Formula |
| 2026-03-13 13:50-14:05 Decoding Human Milk Composition:The Science and Application of Infant Nutrition in China |
| 2026-03-13 14:05-14:20 Establishment,Standardization and Application of a National Human Milk and Maternal-Infant Nutrition Database in China |
| 2026-03-13 14:20-14:35 Unlock HMO Diversity and Synergy:Breakthrough Science and Clinical Research in Early Life Nutrition |
| 2026-03-13 14:35-14:50 Synbiotics:Regulation of Infant Gut Microbiota and Immune Development |
| 2026-03-13 14:50-15:05 Studies on the Short- and Long-Term Health Outcomes of Milk Fat Globule Membrane (MFGM) in Infants and Toddlers |
| 2026-03-13 15:05-15:20 Research Progress and Applications of Structured Lipids in Human Milk |
| 2026-03-13 15:20-15:35 Digital Technology Empowers Precision Health Management for Infants |
| 2026-03-13 15:35-15:50 Unlock innovation in infant formula:naturally occurring HMO's through GOS |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 2:Precise Formulation and Clinical Evidence |
2026-03-13 15:50-17:35 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderators:Jiang YuJun Professor,Vice President of Northeast Agricultural University;Liu Biao Senior Engineer,Inner Mongolia Yili Industrial Group Co.,Ltd，R&D Director |
| 2026-03-13 15:50-16:05 Based on Human Milk Research:Investigation of 3D Fat Globule-Mediated Effects on Infant Health |
| 2026-03-13 16:05-16:20 Infant Brain and Immune Maturation:Rational Design and Clinical Validation of Human Milk-Mimetic Infant Formulas |
| 2026-03-13 16:20-16:35 LIFE Human Milk Research:Six Decades Translating Foundations into Application |
| 2026-03-13 16:35-16:50 A Randomized,Double-Blind,Placebo-Controlled Study Evaluating the Impact of OPO-Enriched Infant Formula on Fat and Calcium Bioavailability,and Infant Defecatory Characteristics |
| 2026-03-13 16:50-17:05 The Health-Promoting Effects of Lactoferrin During Early Life:A Real-World Study in Chinese Infants |
| 2026-03-13 17:05-17:20 Health-Promoting Effects and Clinical Evaluation of Next-Generation HMO-Enriched Formulas |
| 2026-03-13 17:20-17:35 Impact of Bifidobacterium infantis YLGB-1496 Isolated from Chinese Human Milk on the Health Status of Infants and Toddlers Aged 0–36 Months |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 3:Infant Complementary Food |
2026-03-13 09:00-12:00 BFA,The Pavilion |
| |
| 2026-03-13 09:00-09:25 Reflections on Developing a Standards System for Complementary Foods |
| 2026-03-13 09:25-09:50 Scientific Feeding and Complementary Food Design |
| 2026-03-13 09:50-10:15 Standards for Cereal-Based Complementary Foods and Canned Complementary Foods for Infants and Young Children |
| 2026-03-13 10:15-10:40 Standards for Complementary Food SupplementsHuang Jian Professor,Institute of Nutrition and Health,China CDC |
| 2026-03-13 10:40-11:05 Innovative Development of Complementary Foods and the Need for Standards |
| 2026-03-13 11:05-11:30 From the Red Ocean Market to the Deep Sea of Innovation:Scientific Innovation Driving the Development of China’s Complementary Food IndustryLi Chao，Zhejiang Baobao Chanle Food Technology Co.,Ltd. Head of Baobao Chanle Nutrition Research Institute |
| 2026-03-13 11:30-12:00 Roundtable Meeting:High-Quality Development of Complementary Foods and the Need for StandardsModerator:Fang Haiqin |